Summit X LLC Cuts Stake in Oracle Corporation $ORCL

Summit X LLC lessened its holdings in shares of Oracle Corporation (NYSE:ORCLFree Report) by 46.2% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 6,011 shares of the enterprise software provider’s stock after selling 5,167 shares during the quarter. Summit X LLC’s holdings in Oracle were worth $1,314,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in ORCL. LGT Financial Advisors LLC purchased a new position in shares of Oracle in the second quarter worth $33,000. Legend Financial Advisors Inc. bought a new stake in Oracle in the 2nd quarter valued at $34,000. HighMark Wealth Management LLC purchased a new stake in Oracle in the 2nd quarter worth $38,000. Moser Wealth Advisors LLC grew its position in shares of Oracle by 1,770.0% during the second quarter. Moser Wealth Advisors LLC now owns 187 shares of the enterprise software provider’s stock valued at $41,000 after purchasing an additional 177 shares in the last quarter. Finally, Orion Capital Management LLC increased its holdings in shares of Oracle by 32.2% in the second quarter. Orion Capital Management LLC now owns 193 shares of the enterprise software provider’s stock worth $42,000 after purchasing an additional 47 shares during the last quarter. 42.44% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

ORCL has been the subject of a number of research reports. TD Cowen increased their target price on Oracle from $325.00 to $375.00 and gave the company a “buy” rating in a research report on Wednesday, September 10th. Wolfe Research upped their price target on shares of Oracle from $300.00 to $400.00 and gave the company an “outperform” rating in a research note on Wednesday, September 10th. UBS Group lifted their price objective on shares of Oracle from $360.00 to $380.00 and gave the stock a “buy” rating in a research note on Friday, October 17th. Sanford C. Bernstein boosted their target price on shares of Oracle from $363.00 to $364.00 and gave the stock an “outperform” rating in a report on Friday, September 26th. Finally, Stephens increased their price target on shares of Oracle from $208.00 to $331.00 and gave the company an “equal weight” rating in a report on Friday, October 17th. Three investment analysts have rated the stock with a Strong Buy rating, twenty-six have issued a Buy rating, ten have issued a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $323.69.

Read Our Latest Stock Report on Oracle

Insider Transactions at Oracle

In related news, insider Michael D. Sicilia sold 33,845 shares of the firm’s stock in a transaction dated Tuesday, September 23rd. The shares were sold at an average price of $321.16, for a total value of $10,869,660.20. Following the transaction, the insider owned 132,656 shares of the company’s stock, valued at $42,603,800.96. This trade represents a 20.33% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Clayton M. Magouyrk sold 40,000 shares of the business’s stock in a transaction dated Tuesday, October 21st. The shares were sold at an average price of $276.64, for a total transaction of $11,065,600.00. Following the completion of the sale, the chief executive officer directly owned 154,030 shares of the company’s stock, valued at approximately $42,610,859.20. This trade represents a 20.62% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 204,254 shares of company stock valued at $60,227,807. Company insiders own 40.90% of the company’s stock.

Oracle Stock Down 1.9%

Shares of NYSE ORCL opened at $239.15 on Friday. Oracle Corporation has a 1 year low of $118.86 and a 1 year high of $345.72. The firm has a 50-day simple moving average of $279.32 and a two-hundred day simple moving average of $230.60. The company has a market cap of $681.77 billion, a P/E ratio of 55.36, a PEG ratio of 2.96 and a beta of 1.51. The company has a debt-to-equity ratio of 3.33, a current ratio of 0.62 and a quick ratio of 0.62.

Oracle (NYSE:ORCLGet Free Report) last issued its quarterly earnings results on Tuesday, September 9th. The enterprise software provider reported $1.47 earnings per share for the quarter, missing the consensus estimate of $1.48 by ($0.01). Oracle had a return on equity of 72.93% and a net margin of 21.08%.The business had revenue of $14.93 billion during the quarter, compared to analysts’ expectations of $15.04 billion. During the same quarter in the previous year, the company posted $1.39 earnings per share. The company’s quarterly revenue was up 12.2% compared to the same quarter last year. Oracle has set its Q2 2026 guidance at 1.270-1.310 EPS. Research analysts anticipate that Oracle Corporation will post 5 earnings per share for the current year.

Oracle Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, October 23rd. Stockholders of record on Thursday, October 9th were paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date of this dividend was Thursday, October 9th. Oracle’s payout ratio is currently 46.30%.

Oracle Company Profile

(Free Report)

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.

See Also

Want to see what other hedge funds are holding ORCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oracle Corporation (NYSE:ORCLFree Report).

Institutional Ownership by Quarter for Oracle (NYSE:ORCL)

Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.